These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17482094)

  • 21. Vascular calcification and uremia: what do we know?
    Cozzolino M; Mazzaferro S; Pugliese F; Brancaccio D
    Am J Nephrol; 2008; 28(2):339-46. PubMed ID: 18046081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular calcification in chronic kidney disease: mechanisms and clinical implications.
    Ossareh S
    Iran J Kidney Dis; 2011 Sep; 5(5):285-99. PubMed ID: 21876304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation and vascular calcification.
    Moe SM; Chen NX
    Blood Purif; 2005; 23(1):64-71. PubMed ID: 15627739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular calcification: pathobiological mechanisms and clinical implications.
    Johnson RC; Leopold JA; Loscalzo J
    Circ Res; 2006 Nov; 99(10):1044-59. PubMed ID: 17095733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B; Belozeroff V
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The functional cardiovascular consequences of vascular calcification.
    McIntyre CW
    Semin Dial; 2007; 20(2):122-8. PubMed ID: 17374085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiological aspects of vascular calcification in chronic renal failure.
    Drüeke TB
    Nefrologia; 2005; 25 Suppl 2():96-9. PubMed ID: 16050411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
    Pertosa G; Simone S; Ciccone M; Porreca S; Zaza G; Dalfino G; Memoli B; Procino A; Bonomini M; Sirolli V; Castellano G; Gesualdo L; Ktena M; Schena FP; Grandaliano G
    Am J Kidney Dis; 2009 Mar; 53(3):467-74. PubMed ID: 19167798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.
    Shroff RC; McNair R; Figg N; Skepper JN; Schurgers L; Gupta A; Hiorns M; Donald AE; Deanfield J; Rees L; Shanahan CM
    Circulation; 2008 Oct; 118(17):1748-57. PubMed ID: 18838561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.
    Ketteler M; Bongartz P; Westenfeld R; Wildberger JE; Mahnken AH; Böhm R; Metzger T; Wanner C; Jahnen-Dechent W; Floege J
    Lancet; 2003 Mar; 361(9360):827-33. PubMed ID: 12642050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial calcification and stiffness in chronic kidney disease.
    Kerr PG; Guerin AP
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):683-7. PubMed ID: 17581230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
    Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
    Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
    Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
    Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanism, imaging technique and therapy for vascular calcification in patients of chronic kidney disease].
    Yoshida H; Yokoyama K
    Clin Calcium; 2007 May; 17(5):726-33. PubMed ID: 17471002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease.
    Raggi P; Kleerekoper M
    Clin J Am Soc Nephrol; 2008 May; 3(3):836-43. PubMed ID: 18322050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment.
    Kestenbaum B
    Semin Dial; 2007; 20(4):286-94. PubMed ID: 17635817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial calcification in patients with chronic kidney disease.
    Koleganova N; Piecha G; Ritz E; Schirmacher P; Müller A; Meyer HP; Gross ML
    Nephrol Dial Transplant; 2009 Aug; 24(8):2488-96. PubMed ID: 19329792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlated C-reactive protein and calcification inhibitors in hemodialysis patients with cardiovascular parameters and risk factors? About the article in DMW 36/2007].
    Bauer K
    Dtsch Med Wochenschr; 2008 Jan; 133(1-2):44; author reply 44. PubMed ID: 18095212
    [No Abstract]   [Full Text] [Related]  

  • 40. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
    Sigrist MK; Taal MW; Bungay P; McIntyre CW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.